首页> 外文期刊>The Journal of Physiology >CrossTalk proposal: There is added benefit to providing permissive hypercapnia in the treatment of ARDS
【24h】

CrossTalk proposal: There is added benefit to providing permissive hypercapnia in the treatment of ARDS

机译:CrossTalk提议:在ARDS的治疗中,提供允许的高碳酸血症会带来更多好处

获取原文
获取原文并翻译 | 示例
           

摘要

The term 'permissive hypercapnia' was coined after two case series by Hickling and colleagues in the early 1990s that suggested that limitation of airway pressure and tidal volume, with a tolerant approach to elevations in arterial CO2, was associated with lower hospital mortality than predicted by 'acute physiological and chronic health evaluation (APACHE) II' scores (Hickling et al 1990, 1994). In fact directly analogous findings had been reported in the mid 1980s, whereby lowering tidal volumes in status asthmaticus (Darioli & Perret, 1984) and in persistent pulmonary hypertension of the newborn (Wung et al. 1985) was associated with hypercapnia and an apparent improvement in survival.
机译:Hickling及其同事在1990年代初的两个病例系列之后提出了“允许的高碳酸血症”一词,这表明气道压力和潮气量受限,并且可以耐受动脉CO2升高的方法,与医院死亡率相比低于预期。 “急性生理和慢性健康评估(APACHE)II”分数(Hickling等,1990,1994)。实际上,在1980年代中期已经报道了直接相似的发现,由此降低了哮喘状态(Darioli&Perret,1984)和新生儿持续性肺动脉高压(Wung等,1985)的潮气量与高碳酸血症和明显改善有关。在生存中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号